Synthesis of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidines, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines and 1,2,4-triazolo[5,1-i]purines: new potent adenosine A2 receptor antagonists

https://doi.org/10.1016/0223-5234(93)90087-UGet rights and content

Abstract

A number of 2- or 4-fluorobenzylderivatives of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidine, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine and 1,2,4-triazolo[5,1-i] purine have been synthesized. The interaction with the adenosine A2 and A1 receptors was evaluated using selected biological assays. The highest degree of activity was displayed by the 5-amino-2-(2-furyl)-7-(or 8-)-fluorobenzyl-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine 13e, f and 18e, f and -3-fluorobenzyl-1-2-4-triazolo[5,1-i] purines 19e, f. The compound 18f was found to be the most potent A2 antagonist in our series with a selectivity similar to that of the reference compound CGS 15943, but with 75-fold more activity in the platelet aggregation model.

References (20)

  • JW Daly et al.

    Biochem Pharmacol

    (1988)
  • M Williams et al.

    Pharmacol Biochem Behav

    (1988)
  • KS Lee et al.

    Brain Res

    (1986)
  • R Korth et al.

    Eur J Pharmacol

    (1988)
  • C Nordstedt et al.

    Anal Biochem

    (1990)
  • M Williams

    Adenosine and Adenosine Receptors

    (1990)
  • RF Bruns et al.
  • KA Jacobson et al.

    J Med Chem

    (1992)
  • J Shimada et al.

    J Med Chem

    (1992)
  • JE Francis et al.

    J Med Chem

    (1988)
There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 1993 Published by Elsevier Masson SAS